Company intelligence / Profile preview
Hanmi Pharmaceutical
Seoul/Songpa-gu/Wiryeseong-daero, Seoul Special City, South Koreahanmipharm.com ↗
- Ownership
- Public · 128940
- Employees
- ~563
- Development stage
- Phase 1
01
Overview
Hanmi Pharmaceutical has a robust R&D-driven pipeline with more than 130 drug candidates across oncology, metabolic diseases (including diabetes), cardiovascular conditions and others. The company has achieved several firsts for Korean pharma—such as the first novel biologic FDA approval for Rolvedon—and has outlicensed key assets to global partners. Its portfolio includes both innovative new chemical entities and value-added generics/fixed-dose combinations. Clinical results include successful commercialization of multiple products in Korea and internationally.
- Therapeutic areas
- GastroenterologyCardiovascularMetabolic DisordersEndocrinologyOncology
- Modalities
- Small moleculesbiologics (including novel biologics)fixed-dose combinationsincrementally modified drugs
- Industry
- Biotech
02
Drug pipeline
101 assets100 more assets in the full pipeline.
Request access →03
Partnerships
Beyond the preview
Go deeper on Hanmi Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hanmi Pharmaceutical.